Oral Treatment in Selective Vitamin B12 Malabsorption
Authors:
- Mualla ÇetinMÇMualla Çetin
- 1 May 1997
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 19 (3) , 245-246
Abstract
Purpose: The efficacy of oral treatment with megadose vitamin B12 in a patient with selective vitamin BJ2 malabsorption is studied. Patients and Methods: An 8-year-old boy with megaloblastic anemia due to selective vitamin B12 malabsorption is presented. His history was significant for anemia of 4 years duration, requiring transfusion on two occasions. On admission, the Hb was 7.9 g/dL, WBC 6 × 109/L, mean corpuscular volume 124 fl, red cell distribution width 16.8%, platelets 156 × 109/L, reticulocyte 0.04%, and the serum vitamin B12 level 87 pmol/L. There was proteinuria. Replacement treatment with oral B12 1,000 μg/daily was instituted. Results: Reticulocytosis was observed on the third day of treatment, which was followed by a gradual increase in Hb level to 12 g/dL in 3 weeks. A Schilling test performed after a 5-day interruption of therapy was compatible with malabsorption. Conclusions: Our study suggests that the oral route is as effective as the parenteral route when vitamin B12 is given at a dose larger than that of parenteral therapy.Keywords
This publication has 5 references indexed in Scilit:
- Decreased activity of intestinal and urinary intrinsic factor in Gräsbeck-Imerslund diseaseGastroenterology, 1995
- Familial Selective Vitamin B12Malabsorption (Imerslund-Grasbeck Syndrome) in a Pool of Turkish PatientsPediatric Hematology and Oncology, 1995
- Absent ileal uptake of IF-bound vitamin B12 in vivo in the Imerslund-Grasbeck syndrome (familial vitamin B12 malabsorption with proteinuria).Gut, 1985
- Improvisation RevisitedArchives of internal medicine (1960), 1980
- ORAL TREATMENT OF PERNICIOUS ANEMIA WITH HIGH DOSES OF VITAMIN B12 WITHOUT INTRINSIC FACTORActa Medica Scandinavica, 1968